HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endovascular treatment of superior vena cava obstruction in patients with malignancies.

Abstract
The aim of this study was to report our experience on the management of superior vena cava obstruction (SVCO) secondary to malignant disease, using endovascular procedures. Twenty-six patients with SVCO due to primary or secondary tumors of the lung or the mediastinum, or catheter inserted for treatment of an extra-thoracic neoplasm, had an endovascular therapy which consisted of stenting, angioplasty, thrombo-aspiration or local fibrinolysis. Immediately after the procedure, rapid relief of symptoms occurred in 24 (90 %) of the patients. The mean Kishi's score decreased from 5.5 to 0.96. Immediate complications included one death related to pericarditis bleeding following fibrinolysis. Three patients relapsed after 20 days, 4 months and 6 months, and needed a second stenting. At 6 months the primary patency rate was 83 % and the secondary patency rate was 89 %. Endovascular treatment of SVCOs is a simple and safe procedure to restore the patency of the superior vena cava in malignant SVCO. It should be indicated in most cases as first-line treatment and performed as early as possible.
AuthorsF Thony, D Moro, P Witmeyer, S Angiolini, C Brambilla, M Coulomb, G Ferretti
JournalEuropean radiology (Eur Radiol) Vol. 9 Issue 5 Pg. 965-71 ( 1999) ISSN: 0938-7994 [Print] Germany
PMID10370001 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Angioplasty, Balloon
  • Catheterization, Central Venous (adverse effects)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Radiography, Interventional
  • Stents
  • Superior Vena Cava Syndrome (diagnostic imaging, etiology, therapy)
  • Thoracic Neoplasms (complications)
  • Thrombolytic Therapy
  • Thrombosis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: